TrialClinical cancer research : an official journal of the American Association for Cancer Research2008

A phase II trial of erlotinib in combination with bevacizumab in patients with metastatic breast cancer.

Maura N Dickler et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.